Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.62 |
| ▸ | THRB | P10828 | 1/20 | 0.62 |
| ▸ | HTT | P42858 | 1/20 | 0.62 |
| ▸ | MAPT | P10636 | 1/20 | 0.62 |
| ▸ | TSHR | P16473 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.44 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.44 |
| ▸ | ACHE | P22303 | 6/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7792032 | 1.00 | MEN1 (0.62) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL9082343 | 1.00 | MEN1 (0.62) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL2528900 | 1.00 | MEN1 (0.62) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL4948899 | 1.00 | MEN1 (0.62) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL9083409 | 1.00 | MEN1 (0.62) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL8956334 | 1.00 | MEN1 (0.62) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL8813011 | 0.97 | MEN1 (0.60) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL6021572 | 0.97 | MEN1 (0.60) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL16158119 | 0.97 | MEN1 (0.67) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL27269495 | 0.97 | MEN1 (0.67) | MEN1KMT2ATHRBHTTMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 193 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103205241-A | Long-acting antifogging agent for glass and method for manufacturing long-acting antifogging agent | YU WEN | 2013-07-17 | — | — | CN | claimed |
| US-8461135-B2 | Boron-containing small molecules as anti-inflammatory agents | ANACOR PHARMACEUTICALS, INC. (US) | 2013-06-11 | — | — | US | claimed |
| US-8039450-B2 | Boron-containing small molecules as anti-inflammatory agents | ANACOR PHARMACEUTICALS, INC. (US) | 2011-10-18 | — | — | US | claimed |
| US-7419620-B2 | Dichroic mixtures | ROLIC LTD C/O ROLIC TECHNOLOGIES LTD (CH) | 2008-09-02 | — | — | US | claimed |
| EP-1385914-B1 | DICHROIC MIXTURE | ROLIC AG (CH) | 2008-07-23 | — | — | EP | claimed |
| US-20040164272-A1 | Dichoric mixture | ROLIC AG (CH) | 2004-08-26 | — | — | US | claimed |
| EP-1385914-A1 | DICHROIC MIXTURE | Rolic AG (CH) | 2004-02-04 | — | — | EP | claimed |
| WO-2002090447-A1 | DICHROIC MIXTURE | ROLIC AG (CH) | 2002-11-14 | — | — | WO | claimed |
| EP-1256602-A1 | Dichroic mixture | Rolic AG (CH) | 2002-11-13 | — | — | EP | claimed |
| US-20260009053-A1 | METHOD FOR PRODUCING 1,6-HEXANE DIOL COMPOSITION, 1,6-HEXANE DIOL COMPOSITION, AND POLYMER | DIC CORPORATION (JP) | 2026-01-08 | — | — | US | disclosed |
| EP-4559892-A1 | 1,6-HEXANEDIOL COMPOSITION AND POLYMER | DIC Corporation (JP) | 2025-05-28 | — | — | EP | disclosed |
| EP-4559891-A1 | METHOD FOR PRODUCING 1,6-HEXANE DIOL COMPOSITION, 1,6-HEXANE DIOL COMPOSITION, AND POLYMER | DIC Corporation (JP) | 2025-05-28 | — | — | EP | disclosed |
| CN-119384404-A | Process for producing 1, 6-hexanediol composition, and polymer | DIC株式会社 | 2025-01-28 | — | — | CN | disclosed |
| CN-119278194-A | 1, 6-Hexanediol composition and polymer | DIC株式会社 | 2025-01-07 | — | — | CN | disclosed |
| EP-0536936-A1 | Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use | Sankyo Company Limited (JP) | 1993-04-14 | — | — | EP | disclosed |
| EP-0513387-A1 | ACTIVE OXYGEN INHIBITOR | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1992-11-19 | — | — | EP | disclosed |
| EP-0450066-A1 | CARBOSTYRIL DERIVATIVES | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1991-10-09 | — | — | EP | disclosed |
| US-5053548-A | Containing hydroxy substituents; nervous system disorders | OTSUKA PHARMACEUTICAL COMPANY, LTD. (JP) | 1991-10-01 | — | — | US | disclosed |
| EP-0382213-A2 | Biphenyl derivative, nerve cell degeneration repairing or protecting agent and process for preparing a phenyl derivative contained in the agent | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1990-08-16 | — | — | EP | disclosed |
| US-4000258-A | INSECTICIDES, ALCOHOLS, POLYOXYETHYLENE (PROPYLENE) GLYCOL | SANDOZ, INC. (US) | 1976-12-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260009053-A1 | METHOD FOR PRODUCING 1,6-HEXANE DIOL COMPOSITION, 1,6-HEXANE DIOL COMPOSITION, AND POLYMER | HAAO, HPD, HDHD5 | MEN1 3106/4885KMT2A 4637/4885THRB 4235/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.